Product Name: Resmetirom
CAS No.: 919297-36-2
Synonyms: MGL-3196, Thyroid hormone receptor agonist
Molecular Weight: 444.56 g/mol
Chemical Name: [(3,5-dichloro-4-{[4-hydroxy-3-(isopropylamino)phenyl]ethynyl}phenoxy)methyl]benzoic acid

Product Description:
Resmetirom, or MGL-3196, is a selective thyroid hormone receptor-beta agonist with proven efficacy in reducing liver fat and improving metabolic parameters. As a pharmaceutical-grade Resmetirom API, it is widely utilized in clinical research and therapeutic formulations. Leading manufacturers ensure strict adherence to regulatory standards, producing high-purity APIs to aid in developing treatments for NASH and hypercholesterolemia.

Product Usage:
Resmetirom APIs are primarily used to develop therapeutic drugs for:
- Non-alcoholic steatohepatitis (NASH)
- Metabolic disorders
- Cardiovascular diseases

Applications:
- Pharmaceutical API for NASH treatment
- Metabolic disorder therapies
- Cardiovascular drug development
- Clinical research

Quality: High-purity pharmaceutical-grade API manufactured under stringent quality control processes with GMP compliance.

Packaging: Available in various package sizes to meet customer requirements.

Storage: Store in a cool, dry place away from light and moisture.

This is an innovative therapeutic agent for liver disease treatment.